Ready to take the next step in your transformation
This mechanism has made these medications valuable not only for type 2 diabetes management but also for weight management in appropriate patients
Legacy effect of intensive glucose control on major adverse cardiovascular outcome: systematic review and meta-analyses of trials according to different scenarios
These are the most common side effects
McLean BA, Wong CK, Campbell JE, Hodson DJ, Trapp S, Drucker DJ (2021) Revisiting the complexity of GLP-1 action from sites of synthesis to receptor activation
Martin Lange, Executive Vice President for Development at Novo Nordisk, stated, We remain committed to the potential of once-weekly basal insulin icodec for individuals managing diabetes who require basal insulin therapy